Moleac awarded prize from Creative France – recognising the success of French entrepreneurs in Singapore
Moleac awarded prize from Creative France – recognising the success of French entrepreneurs in Singapore “Entrepreneur” is a French invention for risk takers committed to innovate, and Moleac is a complete illustration of successful entrepreneurial biopharmaceutical...
Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery – Extension Study
Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery – Extension Study Cerebrovasc Dis 2017; 43:36-42 Published by S. Karger AG, Basel This analysis from the CHIMES-E study shows that...
Moleac’s Flagship Product NeuroAiD Named Asia Pacific Neurological Disorders New Product Innovation of the Year At the Frost & Sullivan Best Practices Awards
Moleac’s Flagship Product NeuroAiD Named Asia Pacific Neurological Disorders New Product Innovation of the Year At the Frost & Sullivan Best Practices Awards NeuroAiD™ has been named New Product Innovation of the Year by Frost & Sullivan. This award...
NeuroAiD™ has shown persistent long-term benefits after an initial 3-month treatment following stroke onset
NeuroAiD™ has shown persistent long-term benefits after an initial 3-month treatment following stroke onset Moleac is pleased to announce the release of the CHIMES-E study results published online in the journal Cerebrovascular Diseases1 . It provides convincing data...
